Geneception is a company focused on the development of breakthrough in gene and cell therapies that are fully-integrated.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jan 1, 2019 | Series A | — | 2 | — | — | Detail |
Jan 1, 2018 | Seed | — | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
ARCH Venture Partners | — | Series A |
Lilly Asia Ventures | — | Series A |